NAD+-MAX-750
Nicotinamide Adenine Dinucleotide|750 mg × 10 Vials
NAD+-MAX-750 is a research-grade product containing Nicotinamide Adenine Dinucleotide (NAD+), an important cellular coenzyme involved in numerous biochemical and metabolic processes.
Each vial contains 750 mg, with 10 vials per kit, providing a total labeled quantity of 7,500 mg.
Designed for qualified laboratory and research applications, NAD+-MAX-750 provides researchers with a clearly identified NAD+ formulation suitable for controlled experimental workflows.
Product Highlights
About NAD+
Nicotinamide Adenine Dinucleotide (NAD+) is a naturally occurring coenzyme found throughout living cells and plays an important role in numerous biochemical reactions.
NAD+ functions as an important electron carrier in cellular redox reactions and is closely involved in pathways associated with cellular energy metabolism. It also participates in enzyme-mediated processes that are important to cellular function.
Because of its fundamental role in cellular biochemistry, NAD+ has been extensively investigated in areas including cellular metabolism, mitochondrial biology, redox processes, cellular signaling, and DNA-associated cellular pathways.
Research continues to examine NAD+ metabolism, availability, and utilization within different experimental systems.
However, laboratory and preclinical findings should not automatically be interpreted as evidence of therapeutic safety or efficacy in humans. NAD+-MAX-750 is therefore presented as a research compound for qualified laboratory applications, rather than as an approved therapeutic product.
Product Specifications
| PRODUCT NAME | NAD+-MAX-750 |
| COMPOUND | Nicotinamide Adenine Dinucleotide (NAD+) |
| PRODUCT TYPE | Cellular Coenzyme |
| QUANTITY PER VIAL | 750 mg |
| NUMBER OF VIALS | 10 |
| TOTAL QUANTITY | 7,500 mg |
| PRODUCT CATEGORY | Research Compound |
| PHYSICAL FORM | Verify with manufacturer |
| INTENDED APPLICATION | Laboratory / Research Use |
| PACKAGING | 10-vial kit |
| BRAND | Maxtreme Pharma |
Note: The product image establishes the compound identity, 750 mg vial strength, 10-vial configuration, and 7,500 mg total quantity. Physical form, formulation, purity, assay, and other analytical specifications should be confirmed through the manufacturer's current technical documentation or CoA.
Research Applications
NAD+ is widely investigated because of its central role in cellular metabolism and biochemical redox processes. Research areas may include:
Researchers may investigate NAD+ availability, metabolism, and cellular utilization within controlled experimental systems to better understand its role in biological processes. These research areas describe experimental investigation only and do not constitute approved medical indications or recommendations for human use.
NAD+ Research Profile
NAD+ is a central coenzyme involved in oxidation-reduction reactions, functioning through the NAD+/NADH redox couple.
Its role extends beyond energy metabolism, as NAD+ also participates in biochemical pathways involving several classes of cellular enzymes.
This has made NAD+ biology an important area of research involving mitochondrial function, metabolic regulation, redox balance, cellular signaling, and DNA-associated cellular processes.
Researchers continue to investigate how NAD+ synthesis, consumption, and availability influence cellular physiology under different experimental conditions.
Findings from laboratory, cellular, or animal studies should not automatically be extrapolated to therapeutic outcomes in humans.
Quality & Packaging
The NAD+-MAX-750 kit contains 10 individually packaged vials, with 750 mg of labeled NAD+ per vial, providing a total labeled quantity of 7,500 mg per kit.
The packaging clearly identifies the compound as Nicotinamide Adenine Dinucleotide and specifies both the individual vial quantity and total kit configuration.
For professional research procurement, researchers should verify the applicable: Certificate of Analysis (CoA), batch/lot number, compound identity, purity specification, assay results, analytical testing, formulation information, and storage requirements.
For research involving NAD+, batch-specific analytical documentation can help confirm the identity and quality characteristics of the material supplied.
Storage & Handling
Store and handle NAD+-MAX-750 according to the manufacturer's batch-specific technical documentation and Certificate of Analysis.
NAD+ stability may be influenced by factors including temperature, moisture, light exposure, formulation, and handling conditions.
Researchers should follow the manufacturer's documented storage and handling requirements rather than relying on generic storage recommendations. Appropriate laboratory procedures and applicable safety protocols should be followed when handling research-grade NAD+.
NAD+-MAX-750 is a research-grade NAD+ product and is not presented as a drug, dietary supplement, or approved treatment for any medical condition.
This product is intended for qualified research and laboratory applications in accordance with applicable laws, regulations, institutional requirements, and laboratory safety procedures.
No claim is made that NAD+-MAX-750 is safe or effective for the diagnosis, treatment, cure, or prevention of any disease or medical condition.
Not for human consumption or self-administration.
Frequently Asked Questions
NAD+-MAX-750 is a research-grade product containing Nicotinamide Adenine Dinucleotide (NAD+), a cellular coenzyme involved in numerous biochemical and metabolic processes.
Each vial contains 750 mg according to the product packaging.
The kit contains 10 vials.
The kit contains 7,500 mg total, calculated as: 10 vials × 750 mg = 7,500 mg.
NAD+, or Nicotinamide Adenine Dinucleotide, is a cellular coenzyme involved in redox reactions, energy metabolism, and various enzyme-mediated biochemical processes.
No. NAD+ is not a peptide. It is a dinucleotide coenzyme consisting of two nucleotide units.
NAD+ is investigated in areas including cellular energy metabolism, mitochondrial biology, redox reactions, enzyme activity, metabolic pathways, and cellular signaling. These research areas do not constitute approved medical applications.
NAD+ participates in fundamental biochemical reactions and serves as an electron carrier through the NAD+/NADH system. It is therefore an important subject of research into cellular metabolism and redox biology.
The product should not be marketed as an approved treatment for any disease or medical condition. Its appropriate use depends on its specific formulation, intended application, jurisdiction, and applicable regulatory requirements.
No. The product should be presented as For Research Use Only and not for human consumption or self-administration, subject to applicable laws and regulatory requirements.
For professional research procurement, customers should request the applicable Certificate of Analysis (CoA) and batch information. Depending on research requirements, documentation may include identity, purity, assay, analytical testing, formulation, and storage information.